Theralase Technologies Stock Operating Margin
| TTX Stock | 0.14 0.01 6.67% |
Theralase Technologies fundamentals help investors to digest information that contributes to Theralase Technologies' financial success or failures. It also enables traders to predict the movement of Theralase Stock. The fundamental analysis module provides a way to measure Theralase Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theralase Technologies stock.
Theralase |
Theralase Technologies Company Operating Margin Analysis
Theralase Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Theralase Technologies has an Operating Margin of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Operating Margin (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Theralase Fundamentals
| Current Valuation | 47.58 M | |||
| Price To Book | 25.99 X | |||
| Price To Sales | 69.51 X | |||
| Revenue | 780.64 K | |||
| EBITDA | (4.13 M) | |||
| Net Income | (4.41 M) | |||
| Cash Flow From Operations | (4.03 M) | |||
| Market Capitalization | 47.68 M | |||
| Total Asset | 5.94 M | |||
| Net Asset | 5.94 M |
About Theralase Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theralase Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theralase Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theralase Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.